192
Views
71
CrossRef citations to date
0
Altmetric
Original Research

Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models

, , , , , , & show all
Pages 961-970 | Published online: 07 Mar 2013

Figures & data

Figure 1 Schematic of positively charged (AmS-IONPs) and negatively charged (COOH-AmS-IONPs) nanoparticles and their physical properties.

Notes: Measurements were performed in triplicate samples using a Nano-partica SZ-100 series instrument from Horiba. Values represent the mean ± standard error of the mean (n = 3).

Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 1 Schematic of positively charged (AmS-IONPs) and negatively charged (COOH-AmS-IONPs) nanoparticles and their physical properties.Notes: Measurements were performed in triplicate samples using a Nano-partica SZ-100 series instrument from Horiba. Values represent the mean ± standard error of the mean (n = 3).Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 2 bEnd.3 cell (A), astrocyte (B), and neuron (C) viability following a 24-hour exposure to various concentrations of AmS-IONPs.

Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. *Indicates P < 0.05 compared to control; **indicates P < 0.01.

Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 2 bEnd.3 cell (A), astrocyte (B), and neuron (C) viability following a 24-hour exposure to various concentrations of AmS-IONPs.Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. *Indicates P < 0.05 compared to control; **indicates P < 0.01.Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 3 MTT assay of COOH-AmS-IONPs to bEnd.3 cells (A), astrocytes (B), and neurons (C).

Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. ***Indicates P < 0.001 compared to control; +indicates P < 0.05 compared to the same concentration without a magnet.

Abbreviations: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 3 MTT assay of COOH-AmS-IONPs to bEnd.3 cells (A), astrocytes (B), and neurons (C).Notes: Iron content was used to normalize the concentration of various formulated IONPs. Values represent the mean ± standard error of the mean of three samples per treatment group. ***Indicates P < 0.001 compared to control; +indicates P < 0.05 compared to the same concentration without a magnet.Abbreviations: MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 4 Cellular uptake of AmS-IONPs in bEnd.3 cells. Amount of iron accumulation in the cells normalized to protein in time- and concentration-dependent manner (A). The cells were incubated with AmS-IONPs for 1.5 hours at 37°C (B) or 4°C (C).

Note: Values represent the mean ± standard error of the mean of three samples per treatment group.

Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 4 Cellular uptake of AmS-IONPs in bEnd.3 cells. Amount of iron accumulation in the cells normalized to protein in time- and concentration-dependent manner (A). The cells were incubated with AmS-IONPs for 1.5 hours at 37°C (B) or 4°C (C).Note: Values represent the mean ± standard error of the mean of three samples per treatment group.Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 5 Cellular uptake of AmS-IONPs and COOH-AmS-IONPs in bEnd.3 cells (A), astrocytes (B), and neurons (C) at 37°C.

Note: Values represent the mean ± standard error of the mean of three samples per treatment group.

Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 5 Cellular uptake of AmS-IONPs and COOH-AmS-IONPs in bEnd.3 cells (A), astrocytes (B), and neurons (C) at 37°C.Note: Values represent the mean ± standard error of the mean of three samples per treatment group.Abbreviation: AmS-IONPs, aminosilane-coated iron oxide nanoparticles.

Figure 6 TEM images of bEnd.3 cells that were incubated with AmS-IONPs (left) or COOH-AmS-IONPs (right).

Note: Electron-dense particles are visible in intracellular vesicles.

Abbreviations: TEM, transmission electron microscopy; AmS-IONPs, aminosilanecoated iron oxide nanoparticles.

Figure 6 TEM images of bEnd.3 cells that were incubated with AmS-IONPs (left) or COOH-AmS-IONPs (right).Note: Electron-dense particles are visible in intracellular vesicles.Abbreviations: TEM, transmission electron microscopy; AmS-IONPs, aminosilanecoated iron oxide nanoparticles.